These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 15640831)
1. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Mertens F; Fletcher CD; Antonescu CR; Coindre JM; Colecchia M; Domanski HA; Downs-Kelly E; Fisher C; Goldblum JR; Guillou L; Reid R; Rosai J; Sciot R; Mandahl N; Panagopoulos I Lab Invest; 2005 Mar; 85(3):408-15. PubMed ID: 15640831 [TBL] [Abstract][Full Text] [Related]
2. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Guillou L; Benhattar J; Gengler C; Gallagher G; Ranchère-Vince D; Collin F; Terrier P; Terrier-Lacombe MJ; Leroux A; Marquès B; Aubain Somerhausen Nde S; Keslair F; Pedeutour F; Coindre JM Am J Surg Pathol; 2007 Sep; 31(9):1387-402. PubMed ID: 17721195 [TBL] [Abstract][Full Text] [Related]
3. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma. Panagopoulos I; Storlazzi CT; Fletcher CD; Fletcher JA; Nascimento A; Domanski HA; Wejde J; Brosjö O; Rydholm A; Isaksson M; Mandahl N; Mertens F Genes Chromosomes Cancer; 2004 Jul; 40(3):218-28. PubMed ID: 15139001 [TBL] [Abstract][Full Text] [Related]
4. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. Matsuyama A; Hisaoka M; Shimajiri S; Hayashi T; Imamura T; Ishida T; Fukunaga M; Fukuhara T; Minato H; Nakajima T; Yonezawa S; Kuroda M; Yamasaki F; Toyoshima S; Hashimoto H Am J Surg Pathol; 2006 Sep; 30(9):1077-84. PubMed ID: 16931951 [TBL] [Abstract][Full Text] [Related]
5. Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma. Bartuma H; Möller E; Collin A; Domanski HA; Von Steyern FV; Mandahl N; Mertens F Cancer Genet Cytogenet; 2010 Jun; 199(2):143-6. PubMed ID: 20471519 [TBL] [Abstract][Full Text] [Related]
7. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases. Prieto-Granada C; Zhang L; Chen HW; Sung YS; Agaram NP; Jungbluth AA; Antonescu CR Genes Chromosomes Cancer; 2015 Jan; 54(1):28-38. PubMed ID: 25231134 [TBL] [Abstract][Full Text] [Related]
8. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features. Mohamed M; Fisher C; Thway K Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941 [TBL] [Abstract][Full Text] [Related]
9. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887 [TBL] [Abstract][Full Text] [Related]
10. The clinical significance of the FUS-CREB3L2 translocation in low-grade fibromyxoid sarcoma. Rose B; Tamvakopoulos GS; Dulay K; Pollock R; Skinner J; Briggs T; Cannon S J Orthop Surg Res; 2011 Mar; 6():15. PubMed ID: 21406083 [TBL] [Abstract][Full Text] [Related]
11. Primary Renal Hybrid Low-grade Fibromyxoid Sarcoma-Sclerosing Epithelioid Fibrosarcoma: An Unusual Pediatric Case With EWSR1-CREB3L1 Fusion. Mok Y; Pang YH; Sanjeev JS; Kuick CH; Chang KT Pediatr Dev Pathol; 2018; 21(6):574-579. PubMed ID: 29426275 [TBL] [Abstract][Full Text] [Related]
12. FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic tool. Patel RM; Downs-Kelly E; Dandekar MN; Fanburg-Smith JC; Billings SD; Tubbs RR; Goldblum JR Am J Dermatopathol; 2011 Apr; 33(2):140-3. PubMed ID: 21399449 [TBL] [Abstract][Full Text] [Related]
13. EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma. Lau PP; Lui PC; Lau GT; Yau DT; Cheung ET; Chan JK Am J Surg Pathol; 2013 May; 37(5):734-8. PubMed ID: 23588368 [TBL] [Abstract][Full Text] [Related]
14. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features. Warmke LM; Meis JM Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431 [TBL] [Abstract][Full Text] [Related]
16. FUS-CREB3L2/L1-positive sarcomas show a specific gene expression profile with upregulation of CD24 and FOXL1. Möller E; Hornick JL; Magnusson L; Veerla S; Domanski HA; Mertens F Clin Cancer Res; 2011 May; 17(9):2646-56. PubMed ID: 21536545 [TBL] [Abstract][Full Text] [Related]
17. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma. Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156 [TBL] [Abstract][Full Text] [Related]
18. DNA-based polymerase chain reaction for detecting FUS-CREB3L2 in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. Matsuyama A; Hisaoka M; Shimajiri S; Hashimoto H Diagn Mol Pathol; 2008 Dec; 17(4):237-40. PubMed ID: 18382348 [TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of NCC-LGFMS1-C1: a novel patient-derived cell line of low-grade fibromyxoid sarcoma. Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Sei A; Sugaya J; Iwata S; Yoshida A; Kawai A; Kondo T Hum Cell; 2021 Nov; 34(6):1919-1928. PubMed ID: 34535876 [TBL] [Abstract][Full Text] [Related]
20. In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets. Arbajian E; Puls F; Antonescu CR; Amary F; Sciot R; Debiec-Rychter M; Sumathi VP; Järås M; Magnusson L; Nilsson J; Hofvander J; Mertens F Clin Cancer Res; 2017 Dec; 23(23):7426-7434. PubMed ID: 28939748 [No Abstract] [Full Text] [Related] [Next] [New Search]